188 studies found for:    "combined pituitary hormone deficiency" OR "Hypopituitarism"
Show Display Options
Rank Status Study
21 Completed Effect of 5 Years of GH Replacement on Atherosclerosis
Conditions: Hypopituitarism;   Pituitary Tumors;   Growth Hormone Deficiency
Intervention: Drug: Recombinant Growth Hormone, Genotropin (Pfizer)
22 Completed Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
Conditions: Growth Hormone Deficiency;   Septo-Optic Dysplasia;   Hypopituitarism
Intervention: Drug: Nutropin AQ
23 Completed Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency
Condition: Hypopituitarism
Intervention: Drug: Somatropin
24 Unknown  The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin
Conditions: Metabolism;   Insulin Resistance;   Hypopituitarism
Interventions: Drug: Acipimox;   Drug: Ghrelin;   Other: Placebo
25 Completed VRS-317 in Adult Subjects With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: VRS-317
26 Completed Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages
Conditions: Brain Injuries;   Intracranial Aneurysm
Intervention:
27 Active, not recruiting Tumor Classification and Its Application in Surgical Treatment of Craniopharyngioma
Condition: Craniopharyngioma
Intervention: Procedure: Different surgical approach and techniques being used to treat three subtype of CP
28 Completed A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
Condition: Growth Hormone Disorders
Intervention:
29 Completed
Has Results
Genotropin Study Assessing Use of Injection Pen
Conditions: Growth Hormone Deficiency;   Idiopathic Short Stature
Intervention: Device: New Genotropin Pen
30 Unknown  Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)
Conditions: Pseudohypoparathyroidism;   Growth Hormone Deficiency, Dwarfism
Intervention: Drug: recombinant human somatotropin
31 Completed
Has Results
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children;   Foetal Growth Problem;   Small for Gestational Age;   Genetic Disorder;   Turner Syndrome;   Chronic Kidney Disease;   Chronic Renal Insufficiency;   Delivery Systems
Intervention: Drug: Norditropin NordiFlex®
32 Completed Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Intervention: Drug: somatropin
33 Completed Consequence of Lifetime Isolated Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: growth hormone administration for 6 months
34 Terminated Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
Conditions: Growth Hormone Deficiency;   Pituitary Tumor
Intervention:
35 Completed Sustained Release Formulation of Somatropin (rDNA Origin)for Injection
Condition: Growth Hormone Deficiency
Intervention: Drug: BPLG-003
36 Completed Role of Nutrition and Hormones in Boys With Disordered Growth
Conditions: Short Stature;   Constitutional Delay of Growth and Development;   Dwarfism, Pituitary
Intervention: Drug: Growth Hormone Therapy
37 Completed
Has Results
A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
Conditions: Kidney Failure, Chronic;   Growth Hormone Deficiency
Intervention: Drug: Nutropin AQ
38 Completed Growth Hormone Deficiency in Adults (GHDA)
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Intervention: Drug: somatropin
39 Completed Phase 1 Safety Study of ALRN-5281 in Healthy Subjects
Condition: Growth Hormone Deficiency
Interventions: Drug: ALRN-5281 0.015 mg/kg;   Drug: ALRN-5281 0.05 mg/kg;   Drug: ALRN-5281 0.15 mg/kg;   Drug: Placebo 0.015 mg/kg;   Drug: Placebo 0.05mg/kg;   Drug: Placebo 0.15mg/kg
40 Completed Investigation of a New, Oral Growth Hormone Secretagogue, Macimorelin (AEZS-130) as a Growth Hormone Stimulation Test.
Condition: Diagnosis of Adult Growth Hormone Deficiency (AGDH)
Intervention: Drug: diagnostic

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years